Allucent Awarded BARDA Contract
to Support Acceleration of Next-Generation COVID-19 Booster Vaccines
At Allucent, we share your dedication to delivering novel therapies to patients with unmet needs. Designed to serve smaller companies, our organization offers capabilities and expertise that mirror those of larger CROs but delivered with a more personal and flexible style tailored for you. You will always partner with our best experts and gain insights through our consultative, problem-solving approach. Working together, we stay close to the science that drives therapeutic innovation.
A collaborative approach is key to bringing your therapy's potential to light. As your dedicated partner, we offer deep, global experience in clinical trial design and execution, covering complex therapeutic areas and challenging indications. Our mission is to complement your internal capabilities with our expertise to support innovation in treatments for patients with unmet needs.
Small and mid-sized companies need a trusted partner that can support them with all aspects of data management, clinical data analysis, and biostatistics at every point in the development process. Our rigorous biostatistics services clarify your treatment’s efficacy and safety for regulatory bodies while meeting the data requirements of all clinical trial phases. We prioritize data integrity and efficiency, delivering to the highest standards on the most current data platforms.
Companies like yours come to us for one key reason — you trust the depth and breadth of knowledge we bring to your product development challenges, counting on dedicated support from some of the most respected regulatory and technical experts in the field. We can help you with regulatory, clinical, nonclinical, and CMC development planning strategies, health authority meetings, authoring and submission publishing, and support for GxP compliance and pharmacovigilance services.
Clinical pharmacology is essential for the development of safe and effective drugs and therapies. When utilized appropriately, the clinical pharmacology strategy is a road map to guide an efficient clinical development program. With modeling and simulation, prospectively planning and harnessing data from multiple sources will answer many important questions for your development program, including dosing and the value of the drug for patients.
Our specialized focus in Clinical Pharmacology, Model Informed Drug Development (MIDD), Pharmacometrics (PMx), and Pharmacokinetics/Pharmacodynamics (PK/PD) helps our clients improve drug development efficiency and probability of success and avoid costly missteps, including the possibility of regulatory rejection.
When it comes to your government-funded clinical trial, you won’t find another CRO with more experience working through contract negotiations, compliance issues, reporting requirements, and more.
Allucent focuses on supporting breakthrough science from small and mid-sized biotechs because you address the most complex and challenging disease states. Our deep experience and proven expertise in these multifaceted therapeutic areas strengthen your team as you move toward the goal of bringing new hope to patients through the clinical process. Our experts are eager to share their specialized knowledge and partner with you to advance your therapy.
Allucent is focused on serving the needs of small and mid-sized biotechs, and your project will receive the full attention of our top experts – our A-team. Experience in clinical research and regulatory matters permeates our organization. Our employees apply their expertise with a true commitment to working closely with you in developing treatments for patients who need them. Our organizational ethos is devoted to upholding attributes that are fundamental to achieving these goals.